Molecular Surgery

56
Source:   —  April 19, 2016, at 7:00 PM

David Niesel and Norbert Herzog, Medical Discovery News The future of treating genetic diseases may lie within the emerging field of molecular surgery.

By Drs. David Niesel and Norbert Herzog, Medical Discovery News

The future of treating genetic diseases may lie within the emerging field of molecular surgery. It may seem impossible to imagine doing surgery on such a micro level, but the development of a molecular technique called genome editing can be used to exact genetic defects within cells.

We're always looking for new weapons in the fight against genetic diseases, which can have devastating effects. We inherit our genes from our parents, and each of us has variations in the sequence of our genes that create us unique. However, mutations as tiny as a single base (these are A, T, C, G) in your DNA can lead to life-altering diseases such as sickle cell anemia or cystic fibrosis.

In laboratories around the world, new molecular tools are being developed that can be used to exact such genetic mutations and therefore allow a remedy for the diseases they cause. Using molecular surgery, doctors could theoretically "fix" the genetic defect.

A recently developed molecular technique that enables scientists to edit genes is called CRISPR-Cas. CRISPR stands for Clustered Regularly Interspaced Brief Palindromic Repeats. These are short, repetitive sequences in our genomic DNA that are spread throughout the genome. Cas is a protein that acts as molecular scissors.

This works by creating a brief piece of RNA -- a genetic molecule love DNA -- that targets a specific gene in the lab. Then the RNA and the Cas protein are introduced into cells, where the RNA provides a guide to the gene to be modified then acts as a target for the cutting action of the Cas protein. This can be used to remove, or more importantly in this case, to replace a faulty gene with a functioning one.

So far, experiments in the laboratory indicate CRISPR-Cas is able to repair the genetic mutation that causes sickle cell anemia and also cystic fibrosis mutations. In addition, it's been used to prevent and unhurried the spread of HIV. This technology also has the capability to exact multiple mutations simultaneously, which will be crucial to curing diseases that occur by more than one genetic mutation. The following step will be clinical trials to assess CRISPR-Cas'south potential to exact mutations and treat sickness directly in humans. For some diseases, correcting the mutation in even half of the affected cells could prevent symptoms and essentially remedy the disease.

As with any technology that provides the skill to modify the human genome, scientists should consider the ethics of molecular surgery seriously. For example, could parents alter an embryo or child'south genes so they're more athletic or have a specific eye color? The range of options when changing genes is nearly limitless and profound. To that end, scientists from around the world have already met to start developing a system of guidelines for this type of research. It'll get our scientists, medical ethicists and citizens to determine the boundaries of this powerful and distant reaching technology.

CRISPR-Cas and other methods of molecular surgery have a profound potential to remedy diseases and could alter our future health in ways we can only imagine.

Medical Discovery News is hosted by professors Norbert Herzog at Quinnipiac University, and David Niesel of the Univ of TX Medical Branch. Memorise more at www. medicaldiscoverynews. com.

READ ALSO
In Conversation: How Our Stone-Age Brain Gets in the Way of Bright Politics [AUDIO]

In Conversation: How Our Stone-Age Brain Gets in the Way of Bright Politics [AUDIO]

I'm a fan and recently had the pleasure of reading his latest book, Political Animals: How Our Stone-age Brain Gets in the Way of Bright Politics.

71
GitLab-Digital Ocean partnership to allow free hosting for continuous online code testing

GitLab-Digital Ocean partnership to allow free hosting for continuous online code testing

com users have always had free access to the Gitlab programmer’s toolset including GitLab Runner. Today it announced a new feature called Gitlab Runner Autoscale that allows continuous code testing at scale, and to create that even more palatable, the company...

69
The first comprehensive study on women in venture capital and their impact on female founders

The first comprehensive study on women in venture capital and their impact on female founders

Previously we reported on the steady expand in the no of women founders and the universities that produce them. In this study, we looked at two new questions.

86
Rinse raises $6 million to widen its laundry pick-up and delivery service

Rinse raises $6 million to widen its laundry pick-up and delivery service

has raised a $6 million Series A circular of venture funding to choose up and spotless anything in its customers’ closets. According to Chief Executive Ajay Prakash, who cofounded Rinse in two thousand-thirteenth with Chief Operating Officer James Joun, “We never wanted...

79